ClinicalTrials.gov
ClinicalTrials.gov Menu

Serum Markers in Preeclamptic Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01361737
Recruitment Status : Completed
First Posted : May 27, 2011
Last Update Posted : July 6, 2011
Sponsor:
Information provided by:
Oslo University Hospital

Study Description
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Could possible markers in serum obtained in the first trimester predict the human-pregnancy specific disorder pre-eclampsia?

Condition or disease
Preeclampsia

Study Design
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Study Type : Observational
Observational Model: Case Control
Time Perspective: Retrospective
Study Start Date : January 1999
Actual Primary Completion Date : January 1999
Actual Study Completion Date : May 2004

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort
preeclampsia
  • Control group: 86 healthy women not developing preeclampsia (PE)
  • Case group: 43 women developing PE


Outcome Measures
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Eligibility Criteria
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Norwegian pregnant women
Criteria

Inclusion Criteria:

  • previous healthy

Exclusion Criteria:

  • Previous inflammatory diseases
Contacts and Locations
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01361737


Locations
Norway
Oslo University Hospital, Rikshospitalet
Oslo, Norway, 0027
Sponsors and Collaborators
Oslo University Hospital
More Information
Go to 
Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Responsible Party: Oslo University Hospital, Rikshospitalet, OsloUH
ClinicalTrials.gov Identifier: NCT01361737     History of Changes
Other Study ID Numbers: NOSERPE11
First Posted: May 27, 2011    Key Record Dates
Last Update Posted: July 6, 2011
Last Verified: May 2011

Keywords provided by Oslo University Hospital:
Preeclampsia
serological bio-bank
adiponectin
suPAR

Additional relevant MeSH terms:
Pre-Eclampsia
Hypertension, Pregnancy-Induced
Pregnancy Complications